Consensus Rating1
Neutral
Highest Price Target1
$30.00
Lowest Price Target1
$4.50
Consensus Price Target1
$9.78

GoodRx Holdings (NASDAQ:GDRX) Stock, Analyst Ratings, Price Targets, Forecasts

GoodRx Holdings Inc has a consensus price target of $9.78 based on the ratings of 30 analysts. The high is $30 issued by Raymond James on March 2, 2022. The low is $4.5 issued by B of A Securities on January 2, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Citigroup, and Barclays on December 17, 2024, November 13, 2024, and November 11, 2024, respectively. With an average price target of $6.33 between Morgan Stanley, Citigroup, and Barclays, there's an implied 43.61% upside for GoodRx Holdings Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
1
Aug
2
Nov
1
Dec
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.1
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
Citigroup
Barclays
RBC Capital
UBS

1calculated from analyst ratings

Analyst Ratings for GoodRx Holdings

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for GoodRx Holdings (GDRX) stock?

A

The latest price target for GoodRx Holdings (NASDAQ:GDRX) was reported by Morgan Stanley on December 17, 2024. The analyst firm set a price target for $6.00 expecting GDRX to rise to within 12 months (a possible 36.05% upside). 26 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for GoodRx Holdings (GDRX)?

A

The latest analyst rating for GoodRx Holdings (NASDAQ:GDRX) was provided by Morgan Stanley, and GoodRx Holdings maintained their equal-weight rating.

Q

When was the last upgrade for GoodRx Holdings (GDRX)?

A

The last upgrade for GoodRx Holdings Inc happened on May 23, 2024 when RBC Capital raised their price target to $10. RBC Capital previously had a sector perform for GoodRx Holdings Inc.

Q

When was the last downgrade for GoodRx Holdings (GDRX)?

A

The last downgrade for GoodRx Holdings Inc happened on January 2, 2024 when B of A Securities changed their price target from $8 to $4.5 for GoodRx Holdings Inc.

Q

When is the next analyst rating going to be posted or updated for GoodRx Holdings (GDRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoodRx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoodRx Holdings was filed on December 17, 2024 so you should expect the next rating to be made available sometime around December 17, 2025.

Q

Is the Analyst Rating GoodRx Holdings (GDRX) correct?

A

While ratings are subjective and will change, the latest GoodRx Holdings (GDRX) rating was a maintained with a price target of $7.00 to $6.00. The current price GoodRx Holdings (GDRX) is trading at is $4.41, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch